Delenex Therapeutics delenex.com


Public lists: Pharma Startups (6570)

Delenex is a biopharmaceutical company focused on the development of locally or topically applied antibody therapeutics. Thereby Delenex aims at extending the benefits of proven antibody therapeutics to a much larger number of patients. Delenex' proprietary PENTRA platform will deliver such novel, potent and safe antibody therapeutics that are well suited for local/topical application.

Delenex is a biopharmaceutical company focused on the development of locally or topically applied antibody therapeutics. Thereby Delenex aims at extending the benefits of proven antibody therapeutics to a much larger number of patients. Delenex' prop...Show all

Company (Acquired)

Phone: +41-44-730 5180

Fax:

Wagistrasse 27

Schlieren, CH-8952
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Delenex Therapeutics $41.3M Jul 12, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Delenex Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibodies against il-1 beta Jun 16, 2015 Mar 13, 2018 Patent
Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk Dec 16, 2014 Dec 06, 2016 Patent
Binding members to il-1 beta Nov 05, 2013 Aug 02, 2016 Patent
Humanized antibodies against the beta-amyloid peptide Nov 02, 2012 Mar 01, 2016 Patent
Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk Jan 31, 2011 Feb 03, 2015 Patent
See all 7 patents